Guest writer Matthew Busch says that, despite the setbacks and surgeries he's endured, he's now thriving in life with Duchenne MD.

The FDA's verdict on PTC's Translarna could spell the end for the drug's decades-long and tumultuous US DMD development ...

Israel’s MedTech and health innovation landscape: From Tel Aviv to Jerusalem – will seek to share a taste of those insights gleaned during that five-day press trip. It is hoped that some small part of ...

My twin sister spent years moving through consultations without a clear explanation for her symptoms. At one point, aged 31, she was told it was “wear and tear”. At another, she was advised she might ...